Stryker To Pay $1.4M Over Bone Protein Marketing
Stryker Biotech LLC has agreed to pay $1.35 million to Massachusetts to settle claims that the company marketed its OP-1 bone protein for uses not approved by the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article